Akso Health Group (AHG)
0.93
+0.03
(+3.33%)
USD |
NASDAQ |
Apr 18, 16:00
0.93
0.00 (0.00%)
After-Hours: 20:00
Akso Health Group Shareholders Equity (Quarterly): 5.223M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2023 | 5.223M |
| September 30, 2023 | 5.223M |
| March 31, 2023 | 8.725M |
| September 30, 2022 | 9.913M |
| September 30, 2022 | 9.913M |
| March 31, 2022 | 12.28M |
| September 30, 2021 | 19.55M |
| March 31, 2021 | 17.27M |
| September 30, 2020 | 27.05M |
| September 30, 2019 | 100.38M |
| Date | Value |
|---|---|
| June 30, 2019 | 114.56M |
| March 31, 2019 | 126.50M |
| December 31, 2018 | 120.52M |
| September 30, 2018 | 128.18M |
| June 30, 2018 | 164.73M |
| March 31, 2018 | 140.04M |
| December 31, 2017 | 118.85M |
| September 30, 2017 | 46.11M |
| June 30, 2017 | 32.83M |
| March 31, 2017 | 23.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
5.223M
Minimum
Sep 2023
114.56M
Maximum
Jun 2019
30.01M
Average
12.28M
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
| Universe Pharmaceuticals Inc | 39.53M |
| Sinovac Biotech Ltd | 8.665B |
| CASI Pharmaceuticals Inc | 24.16M |
| Zai Lab Ltd | 796.12M |
| I-MAB | 337.31M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 16.88M |
| Total Liabilities (Quarterly) | 11.55M |
| Debt to Equity Ratio | 0.067 |
| Current Ratio | 1.462 |
| Net Debt Paydown Yield | -0.49% |